ConductScience.org, home

Paper20847201

Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.

Iannaccone CK and 8 others. Rheumatology (Oxford), 2011. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Papers, record 20847201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20847201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.
PubMed
Journal
Rheumatology (Oxford)
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
3.01
iCite
Revised in PubMed
2022-04-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iannaccone CKChristine K
2Lee YCYvonne C
3Cui JJing
4Frits MLMichelle L
5Glass RJRoberta J
6Plenge RMRobert M
7Solomon DHDaniel H
8Weinblatt MEMichael E
9Shadick NANancy A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antirheumatic AgentsMajor topic
Arthritis, RheumatoidMajor topic
Genetic Predisposition to DiseaseMajor topic
Tumor Necrosis Factor-alphaMajor topic
Biomarkers
Cohort Studies
Female
Humans
Middle Aged
Registries
Severity of Illness Index
Surveys and Questionnaires
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
42014144Associations between achieving treatment targets and functional and economic outcomes in patients with rheumatoid arthritis: retrospective cohort analyses of BRASS registry data.BMJ Open2026https://conductscience.org/library/papers/42014144PubMed
41972843Inferring Rheumatoid Arthritis Disease Activity Status From the Electronic Health Records Across Health Systems.Arthritis Rheumatol2026https://conductscience.org/library/papers/41972843PubMed
41757188Biomarkers for Atherosclerotic Cardiovascular Events in Rheumatoid Arthritis: Towards Validation of a Biomarker-Enhanced Risk Model.medRxiv2026https://conductscience.org/library/papers/41757188PubMed
41245987Comparison of PREVENT with the pooled cohort equation for estimating atherosclerotic cardiovascular disease risk among patients with rheumatoid arthritis.Am J Prev Cardiol2025https://conductscience.org/library/papers/41245987PubMed
40362255Genetic Variants of the ATIC Gene and Therapeutic Response to Methotrexate in Patients with Rheumatoid Arthritis.Int J Mol Sci2025https://conductscience.org/library/papers/40362255PubMed
39562277Artificial intelligence as an assistant for studying treatment response in rheumatoid arthritis.Semin Arthritis Rheum2025https://conductscience.org/library/papers/39562277PubMed
38898318Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.Clin Rheumatol2024https://conductscience.org/library/papers/38898318PubMed
37556424Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process.PLoS One2023https://conductscience.org/library/papers/37556424PubMed
37269020Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis.Arthritis Res Ther2023https://conductscience.org/library/papers/37269020PubMed
37237405Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry.Arthritis Res Ther2023https://conductscience.org/library/papers/37237405PubMed
36874209Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case-control study.Lancet Rheumatol2023https://conductscience.org/library/papers/36874209PubMed
36009355Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis.Biomedicines2022https://conductscience.org/library/papers/36009355PubMed
35831345Genetic variations in methotrexate metabolic pathway genes influence methotrexate responses in rheumatoid arthritis patients in Malaysia.Sci Rep2022https://conductscience.org/library/papers/35831345PubMed
35738804Meaning of patient global assessment when joint counts are low in rheumatoid arthritis.RMD Open2022https://conductscience.org/library/papers/35738804PubMed
35497687The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population.Evol Bioinform Online2022https://conductscience.org/library/papers/35497687PubMed
34875040Screening for preclinical parenchymal lung disease in rheumatoid arthritis.Rheumatology (Oxford)2022https://conductscience.org/library/papers/34875040PubMed
33615723Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation.Arthritis Rheumatol2021https://conductscience.org/library/papers/33615723PubMed
33191286Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease.J Rheumatol2021https://conductscience.org/library/papers/33191286PubMed
33059295Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality.Semin Arthritis Rheum2020https://conductscience.org/library/papers/33059295PubMed
33002337Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry.Arthritis Care Res (Hoboken)2021https://conductscience.org/library/papers/33002337PubMed

See all 66 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATIC471PubTator's text mininghttps://conductscience.org/library/genes/471NCBI Gene
CEBPD1052PubTator's text mininghttps://conductscience.org/library/genes/1052NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20847201

GET https://conductscience.org/api/papers/v1/20847201/cited_by?page=2